Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects
Drug Discovery Today (2022) - Comment
pubmed: 34624510  doi: 10.1016/j.drudis.2021.09.020  issn: 1359-6446  issn: 1878-5832 

Sepideh Mirzaei, Mohammad Hossein Gholami, Farid Hashemi, Amirhossein Zabolian, Mahdi Vasheghani Farahani, Kiavash Hushmandi, Ali Zarrabi, Aaron Goldman, Milad Ashrafizadeh, Gorka Orive